Ligand validation:2I07

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 2I07 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2I07_NAG_B_1	6%	68%	0.391	0.832	0.55	0.67	-	-	0	0	100%	0.9333
2ICF_NAG_B_5	58%	50%	0.072	0.849	0.62	1.28	-	1	0	0	100%	0.9333
7NOZ_NAG_F_801	25%	61%	0.213	0.846	0.5	0.99	-	1	0	0	100%	0.9333
2XWJ_NAG_I_1353	23%	55%	0.228	0.85	0.42	1.3	-	1	0	0	100%	0.9333
5FO9_NAG_D_1063	22%	68%	0.264	0.884	0.5	0.73	-	-	1	0	100%	0.9333
2WIN_NAG_L_1746	22%	68%	0.262	0.88	0.52	0.69	-	-	0	1	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
5O59_NAG_A_601	100%	70%	0.024	0.993	0.3	0.85	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.